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Foreword
This issue of The Yale Journal of Biology and Medicine is composed of papers
presented at the Symposium on Advances in Transfusion Medicine-1990: The
Challenge ofthe Next Decade, which was held in Farmington, Connecticut, May 4-5,
1990. The Symposium, sponsored by Yale University School of Medicine, Harvard
Medical School, and the Connecticut Red Cross Blood Services, was funded in part by
NHLBI Transfusion Medicine Academic Awards to Yale and Harvard. The Sympo-
sium presented an update on advances in knowledge which will probably have a broad
impact on transfusion medicine during the 1990s.
Five sections are presented in this issue. Section I on "Transfusion-Transmitted
Diseases" includes a discussion by Dr. Bove on various transfusion-transmitted dis-
eases that are less frequentlyreviewed, including babesiosis, Lymedisease, and Chagas
disease; a review by Dr. Sandler on the current status ofretroviral infections HIV and
HTLV-I; and a discussion ofvirally inactivated factor concentrates, by Dr. Horowitz.
"Regulation of Hematopoiesis" is addressed in Section II with an overview ofcellular
maturation presented by Dr. Smith. Dr. Bunn then reviews the status oferythropoietin
and future implications for its use, while those of the granulocyte and monocyte
colony-stimulating factors arecovered by Dr. Antman; Dr. Hoffman closes the section
with a discussion of the new field of megakaryocytic growth factors. Section III
considers the "Immunologic Effects of Blood Transfusion," including a discussion by
Dr. Snyder on the importance of leukocyte depletion in transfusion medicine; a paper
by Dr. Blumberg concerning the data that blood transfusion may have significant
effects on morbidity and recurrence rates for cancer, as well as on the incidence of
infections; Dr. Carpenter continues with a review ofthe transfusion effect as it relates
to organ transplantation, and, last, the relationship between blood transfusions and
graft-versus-host disease is covered by Dr. Rappeport. Section IV relates to the "Role
of Blood Group Antigens in Human Disease." Dr. Marsh here discusses the impor-
tance of the Kell, Duffy, and Rh antigen systems in this regard; Dr. Agre reviews in
detail the biochemistry and structure of the Rh antigen polypeptides; Dr. Beardsley
covers the platelet membrane glycoproteins and their relationship to clinical disease,
and, last, Dr. Kruskall delves into the relationship between HLA antigens, the MHC
loci, and the immune response. The final Session (V) ofthe Symposium was presented
by the nursing staff from Yale University School of Medicine, Harvard Medical
School, and the Connecticut Red Cross. "Bone Marrow Transplantation-1990:
Implication for Nursing Practice" covers an area which is becoming ofmore and more
concern at smaller hospitals as bone marrow transplantation becomes commonplace.
Nurse Holmes covered nursing considerations during the pre-bone marrow transplant
period, while Nurses Poliquin and McGarigle discuss short-term post-transplant
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patient management and long-term follow-up of bone marrow transplant patients,
respectively.
The "Ethical, Psychosocial, and Legal Aspects of Bone Marrow Transplantation"
also must beconsidered. Nurse Yankediscusses theimportance ofrecruiting unrelated
bone marrow donors; Dr. Patenaude covers the increasingly important psychosocial
aspects ofbone marrow transplantation and how these types ofproblems are dealt with
by patients as well as by staff and families. Finally, Attorney Holder covers the legal
aspects of bone marrow transplantation, which are fast becoming more important in
our increasingly litigious society. The papers presented at this Symposium, we believe,
will provide the readers of The YaleJournalofBiologyandMedicine with insight into
both the current trends in the field and the important areas of growth in transfusion
medicine. How the 1990 advances and challenges in transfusion medicine will differ
from those which we will face in the year 2000 remain to be seen.
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